Answers are grounded in this paper and cite their sources.
Aim The nerve growth factor receptor (NGFR) is implicated in tumor progression, but its specific role and mechanism in gastric cancer microenvironment remain unclear. In the present study, we aimed to investigate the potential function of NGFR in the progression and anti-tumor immunity of gastric cancer. Methods The clinical significance of NGFR was analyzed in GC patient samples. Flow cytometry, co-culture assays, western blot, transwell assays, animal models were performed to evaluate the influence of NGFR on gastric cancer progression and tumor microenvironment. Results Our results indicated that high NGFR expression was correlated with advanced tumor stage, metastasis, and poor patient survival of gastric cancer patients. Functionally, NGFR promoted proliferation, migration, invasion, and metastasis of gastric cancer cells. Mechanistically, NGFR overexpression skewed the tumor microenvironment towards a Th2-dominant state by activating the NF-κB pathway and increasing IL-10 secretion, which consequently impaired the cytotoxic function of CD8 + T cells. Furthermore, NGFR overexpression conferred resistance to anti-PD-1 immunotherapy, while pharmacological inhibition of NGFR synergized with PD-1 blockade to suppress tumor growth. Conclusion NGFR drives gastric cancer progression and metastasis, and remodels the immune microenvironment towards an immunosuppressive Th2-polarized state, thereby compromising anti-tumor immunity. Targeting NGFR presents a promising strategy to overcome immune resistance in gastric cancer.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: